Quotient Limited (QTNT)

0,3800 0,0000 (0,00%) Börsenschluss: 04:00PM EST

Quotient Limited

Business Park Terre Bonne
Route de Crassier 13
Eysins 1262
Switzerland
11 41 22 716 9800
https://www.quotientbd.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 450

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Manuel O. Mendez	CEO & Director	10,22M	N/A	1968
Mr. Ali Kiboro	Chief Financial Officer	798,9k	N/A	1975
Mr. Mohammad El Khoury	Chief Commercial Officer	544,83k	N/A	1960
Ms. Vittoria Bonasso	Head of Fin., Group Controller & Principal Accounting Officer	N/A	N/A	1976
Dr. Michael Hausmann	Chief Technology Officer	N/A	N/A	N/A
Dr. Christine Ginocchio	Chief Scientific & Medical Officer	N/A	N/A	N/A
Ms. Viviane Montarnal	Head of Legal Affairs & Compliance	N/A	N/A	N/A
Ms. Hyatt Antognini-Amin	Head of Corp. Communications	N/A	N/A	N/A
Mr. Christian Albrich	Chief People Officer	N/A	N/A	1964
Mr. Esteban Uriarte	Chief Manufacturing Operations Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Corporate Governance

Quotient Limiteds ISS Governance QualityScore, Stand 1. Januar 2023, lautet 8. Die grundlegenden Scores sind Audit: 10, Vorstand: 4, Shareholderrechte: 3, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.